newdrugapprovals.org
MHLW JAPAN has approved Nippon Shinyaku Co’s Regtect (acamprosate) for support maintenance of abstinence in patients with alcohol dependence
ACAMPROSATE MAR 26 2013 MHLW JAPAN has approved Nippon Shinyaku Co’s Regtect (acamprosate) for support maintenance of abstinence in patients with alcohol dependence. Acamprosate, also known …